A Framework for Equitable Allocation of Vaccine for the Novel Coronavirus

Webinar

Final Report Public Release Webinar: Framework for Equitable Allocation of COVID-19 Vaccine

October 2, 2020

10:00 AM - 11:00 AM (ET)

Past

Materials

Public Release Webinar Presentation Slides

About

The Committee on Equitable Allocation of Vaccine for the Novel Coronavirus will discuss its new report, titled Framework for Equitable Allocation of COVID-19 Vaccine. This free public release webinar will take place on Friday, October 2, 2020 from 10:00-11:00am ET.

The release of the final report follows the September release of a discussion draft that sought public input. In addition to an updated framework for equitable allocation of COVID-19 vaccine, the final report includes recommendations for ensuring equity in distribution, administration, and access to vaccine; for effective community engagement, risk communication, and strategies to promote vaccine acceptance; and for global considerations.

Additional Information

Is it a Closed Session event?

Not Closed

Contact

Lisa Brown

COVIDvaccineframework@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Meeting Closed

Committee on Equitable Allocation of Vaccine for the Novel Coronavirus: Committee Meeting 7

September 14, 2020

11:00 AM - 1:00 PM (ET)

Past

About

Virtual closed meeting of the Committee on Equitable Allocation of Vaccine for the Novel Coronavirus.

Additional Information

Is it a Closed Session event?

Institution Closed

The following committee members were present at the closed sessions of the event

1. William Foege
2. Helene Gayle
3. Margaret Brandeau
4. Alison Buttenheim
5. R. Alta Charo
6. James Childress
7. Ana Diez Roux
8. Abigail Echo-Hawk
9. Christopher Elias
10. Baruch Fischhoff
11. David Michaels
12. Jewel Mullen
13. Saad Omer
14. Daniel Polsky
15. Sonja Rasmussen
16. Art Reingold
17. Reed Tuckson
18. Michael Wasserman

The following topics were discussed in the closed sessions:

• Discussion of Draft Recommendations

The following materials (written documents) were made available to the committee in the closed sessions:

• Draft Recommendations

Date of posting of Closed Session Summary:

September 14, 2020

Contact

Lisa Brown

COVIDvaccineframework@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Meeting Closed

Committee on Equitable Allocation of Vaccine for the Novel Coronavirus: Committee Meeting 6

September 8, 2020

1:00 PM - 4:00 PM (ET)

Past

About

Virtual closed meeting of the Committee on Equitable Allocation of Vaccine for the Novel Coronavirus.

Additional Information

Is it a Closed Session event?

Institution Closed

The following committee members were present at the closed sessions of the event

1. William Foege
2. Helene Gayle
3. Margaret Brandeau
4. Alison Buttenheim
5. R. Alta Charo
6. James Childress
7. Ana Diez Roux
8. Abigail Echo-Hawk
9. Christopher Elias
10. Baruch Fischhoff
11. David Michaels
12. Jewel Mullen
13. Saad Omer
14. Daniel Polsky
15. Sonja Rasmussen
16. Art Reingold
17. Reed Tuckson
18. Michael Wasserman

The following topics were discussed in the closed sessions:

• Discuss revisions to be made to the foundational principles, primary goal, allocation criteria, and allocation phases in response to comments from the public.
• Focus on finalizing the remaining sections related to program administration, vaccine hesitancy, risk communications and community engagement, and global considerations.
• Discuss and finalize report recommendations
• Discuss remaining timeline and current work plan

The following materials (written documents) were made available to the committee in the closed sessions:

• Briefing Book

Date of posting of Closed Session Summary:

September 10, 2020

Contact

Lisa Brown

COVIDvaccineframework@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Meeting

Public Listening Session: Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine

September 2, 2020

12:00 PM - 5:00 PM (ET)

Past

Materials

Public Listening Session PowerPoint

About

On Wednesday, September 2, from 12:00 to 5:00 pm ET, the National Academies of Sciences, Engineering, and Medicine will host an open online session to receive public comments on a Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine, as part of a study sponsored by the National Institutes of Health and the Centers for Disease Control and Prevention. The study will recommend priorities to inform allocation of a limited initial supply of COVID-19 vaccine, taking into account factors such as racial/ethnic and other health disparities, as well as groups at higher risk from COVID-19 due to health status, occupation, or living conditions. Input from the public, especially communities highly impacted by COVID-19, is essential to produce a final report that is objective, balanced, and inclusive.

A discussion draft of the preliminary framework will be available for download starting 24 hours advance of the session, on Tuesday, September 1, at 12:00 pm ET. The draft can be accessed at nationalacademies.org/VaccineAllocationComment and the comment form can be accessed at nap.edu/vaccine.

If you would like to make a comment on September 2, please complete our speaker sign-up form (in addition to registering for the event using the signup on this page). Please note that, due to time constraints, we cannot guarantee that that all of those who sign up to make comments will be selected to do so.

You will receive a confirmation email and follow-up contact with further instructions dependent on whether or not you are selected to speak. You may make a comment as an individual or on behalf of an organization. All members of the public selected to speak will be given a specific time slot during the session and must limit their remarks to 5 minutes. Only those who receive a time slot and additional instructions from National Academies staff will be afforded time to speak. Due to the large volume of interested parties and limited time available, we cannot guarantee the opportunity to make oral comments for all those who sign up using the above form. Therefore, we encourage you to consider the written comment opportunity from September 1 to September 4 (more information below). Please contact COVIDVaccineFramework@nas.edu with questions.

You may also attend the September 2 session without making a comment. Simply register to attend using this Eventbrite registration and no further action is required.

Written Comment Period: September 1 (12:00 pm ET) - September 4, 2020 (11:59 pm ET)

Members of the public are encouraged to submit written comments for consideration by the study committee (as individuals or on behalf of an organization). The public comment period will be open for 4 days, from 12:00 p.m. ET on Tuesday, September 1, until 11:59 p.m. ET on Friday, September 4. Commenters will be able to download and review the discussion draft before submitting a comment through a form (uploaded documents accepted). All materials and comments received will be placed in the committee’s Public Access File, and may be provided to the public upon request. The discussion draft and comment form will be available at nationalacademies.org/VaccineAllocationComment starting at 12:00 pm ET on September 1.

For more information, please visit the study webpage.

Additional Information

Is it a Closed Session event?

Not Closed

Contact

Lisa Brown

COVIDvaccineframework@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Meeting Closed

Committee on Equitable Allocation of Vaccine for the Novel Coronavirus: Committee Meeting 5

August 21, 2020

3:00 PM - 6:00 PM (ET)

Past

About

Virtual closed meeting of the Committee on Equitable Allocation of Vaccine for the Novel Coronavirus.

Additional Information

Is it a Closed Session event?

Institution Closed

The following committee members were present at the closed sessions of the event

1. William Foege
2. Helene Gayle
3. Margaret Brandeau
4. Alison Buttenheim
5. R. Alta Charo
6. James Childress
7. Ana Diez Roux
8. Abigail Echo-Hawk
9. Christopher Elias
10. Baruch Fischhoff
11. David Michaels
12. Jewel Mullen
13. Saad Omer
14. Daniel Polsky
15. Sonja Rasmussen
16. Art Reingold
17. Reed Tuckson
18. Michael Wasserman

The following topics were discussed in the closed sessions:

• Reflected on the discussion draft of the framework that was submitted for external review
• Discussed any critical reviewer comments on the discussion draft of the framework and discussed next steps for addressing reviewer comments
• Discussed program administration, evaluation, and assessment issues to ensure effectiveness and equity
• Discussed vaccine hesitancy, risk communication, and community engagement considerations
• Discussed global considerations
• Discussed draft report recommendations
• Discussed remaining timeline and current work plan
• Identified information needs and potential approach to the upcoming virtual public listening session held under the committee’s auspices

The following materials (written documents) were made available to the committee in the closed sessions:

• Briefing Book
• Background Literature

Date of posting of Closed Session Summary:

August 25, 2020

Contact

Lisa Brown

COVIDvaccineframework@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Meeting Closed

Committee on Equitable Allocation of Vaccine for the Novel Coronavirus: Committee Meeting 4

August 14, 2020

3:00 PM - 6:00 PM (ET)

Past

About

Virtual closed meeting of the Committee on Equitable Allocation of Vaccine for the Novel Coronavirus.

Additional Information

Is it a Closed Session event?

Institution Closed

The following committee members were present at the closed sessions of the event

1. William Foege
2. Helene Gayle
3. Margaret Brandeau
4. Alison Buttenheim
5. R. Alta Charo
6. James Childress
7. Abigail Echo-Hawk
8. Christopher Elias
9. Baruch Fischhoff
10. David Michaels
11. Jewel Mullen
12. Saad Omer
13. Daniel Polsky
14. Sonja Rasmussen
15. Art Reingold
16. Reed Tuckson
17. Michael Wasserman

The following topics were discussed in the closed sessions:

• Overarching goals and guiding principles of the allocation framework
• The priority populations and phases
• Various scenarios that the committee will need to consider in applying its framework (e.g., different characteristics of vaccines and differing available doses, different populations, and means of dispensing vaccines)
• The draft outline of the report and draft text completed up to this point
• Current work plan and finish assigning writing roles as needed
• Identify draft report recommendations
• Identify information needs and future workshop approach

The following materials (written documents) were made available to the committee in the closed sessions:

• Briefing Book
• Background Literature

Date of posting of Closed Session Summary:

August 17, 2020

Contact

Lisa Brown

COVIDvaccineframework@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Meeting

Committee on Equitable Allocation of Vaccine for the Novel Coronavirus: Committee Meeting 3

August 7 - 8, 2020

Past

Materials

About

Virtual meeting of the Committee on Equitable Allocation of Vaccine for the Novel Coronavirus is open to the public on August 7 from 3:15 p.m. - 6:15 p.m. ET. Please refer to the final agenda for additional details.

Additional Information

Is it a Closed Session event?

Partially Closed

The following committee members were present at the closed sessions of the event

1. William Foege
2. Helene Gayle
3. Margaret Brandeau
4. Alison Buttenheim
5. R. Alta Charo
6. James Childress
7. Ana Diez Roux
8. Christopher Elias
9. Baruch Fischhoff
10. David Michaels
11. Jewel Mullen
12. Saad Omer
13. Daniel Polsky
14. Sonja Rasmussen
15. Art Reingold
16. Reed Tuckson
17. Michael Wasserman

The following topics were discussed in the closed sessions:

• Overarching goals and cross-cutting principles of the allocation framework
• Discussion of draft report
• Various scenarios that the committee will need to consider in applying its framework (e.g., different characteristics of vaccines and differing available doses, different populations, and means of dispensing vaccines)
• Hierarchy of vaccine recipients, and specifically priority populations and tiers
• Information needs, future meeting topics, and potential approach to writing assignments.

The following materials (written documents) were made available to the committee in the closed sessions:

• Briefing Book
• Background Literature

Date of posting of Closed Session Summary:

August 10, 2020

Contact

Lisa Brown

COVIDvaccineframework@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Meeting Closed

Committee on Equitable Allocation of Vaccine for the Novel Coronavirus: Committee Meeting 2

July 31 - August 1, 2020

Past

About

Virtual closed meeting of the Committee on Equitable Allocation of Vaccine for the Novel Coronavirus.

Additional Information

Is it a Closed Session event?

Institution Closed

The following committee members were present at the closed sessions of the event

1. William Foege
2. Helene Gayle
3. Margaret Brandeau
4. Alison Buttenheim
5. R. Alta Charo
6. James Childress
7. Ana Diez Roux
8. Abigail Echo-Hawk
9. Christopher Elias
10. Baruch Fischhoff
11. David Michaels
12. Jewel Mullen
13. Saad Omer
14. Daniel Polsky
15. Sonja Rasmussen
16. Art Reingold
17. Reed Tuckson
18. Michael Wasserman

The following topics were discussed in the closed sessions:

• Overarching goals and cross-cutting principles of the allocation framework
• Various scenarios that the committee will need to consider in applying its framework (e.g., different characteristics of vaccines and differing available doses)
• Hierarchy of vaccine recipients, and specifically priority populations and tiers
• Need for modeling (demographics of risk groups, epidemic spread in key populations)
• Information needs, future meeting topics, and potential approach to the upcoming virtual public workshop held under the committee’s auspices

The following materials (written documents) were made available to the committee in the closed sessions:

• Briefing Book
• Background Literature

Date of posting of Closed Session Summary:

August 04, 2020

Contact

Lisa Brown

COVIDvaccineframework@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Meeting

Committee on Equitable Allocation of Vaccine for the Novel Coronavirus: Committee Meeting 1

July 24, 2020

3:00 PM - 6:00 PM (ET)

Past

Agenda

Download the Agenda

About

Virtual meeting of the Committee on Equitable Allocation of Vaccine for the Novel Coronavirus is open to the public from 4:30 p.m. - 5:30 p.m. ET. Please refer to the final agenda for additional details.

Additional Information

Is it a Closed Session event?

Partially Closed

The following committee members were present at the closed sessions of the event

1. William Foege
2. Helene Gayle
3. Margaret Brandeau
4. Alison Buttenheim
5. R. Alta Charo
6. James Childress
7. Ana Diez Roux
8. Abigail Echo-Hawk
9. Christopher Elias
10. Baruch Fischhoff
11. David Michaels
12. Jewel Mullen
13. Saad Omer
14. Daniel Polsky
15. Sonja Rasmussen
16. Art Reingold
17. Reed Tuckson

The following topics were discussed in the closed sessions:

• Overview of the committee process and related administrative issues
• Standard bias and conflict of interest discussion according to NRC procedures
• Overview of the study (meeting timeline and discussion on how to frame the draft report)
• Discussion of the Statement of Task and how to approach it

The following materials (written documents) were made available to the committee in the closed sessions:

• Briefing Book
• Background Literature

Date of posting of Closed Session Summary:

July 31, 2020

Contact

Lisa Brown

COVIDvaccineframework@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Log In

Sign in to access your saved publications, downloads, and email preferences.

Former MyNAP users: You'll need to reset your password on your first login to MyAcademies. Click "Forgot password" below to receive a reset link via email. Having trouble? Visit our FAQ page to contact support.

Members of the National Academy of Sciences, National Academy of Engineering, or National Academy of Medicine should log in through their respective Academy portals.

Email (required)
Password (required)

Don't have an account?

Register

Email (required)
New password (required)
Retype password (required) Password must be at least 8 characters
I accept the terms of use
terms of use

Thank You

Thank you for creating a MyAcademies account!

Enjoy free access to thousands of National Academies' publications, a 10% discount off every purchase, and build your personal library.

Forgot Password

Enter the email address for your MyAcademies (formerly MyNAP) account to receive password reset instructions.

Reset Requested

We sent password reset instructions to your email . Follow the link in that email to create a new password. Didn't receive it? Check your spam folder or contact us for assistance.

Reset Password

New password (required)
Retype password (required) Password must be at least 8 characters

Reset Password

Your password has been reset.

Log In

Verify email

Verify Your Email Address

We sent a verification link to your email. Please check your inbox (and spam folder) and follow the link to verify your email address. If you did not receive the email, you can request a new verification link below

Subscribe

First Name
Last Name
Email (required)
I agree to receive emails from the National Academies (required)

We respect your privacy and will never share your information.

My Academies

A Framework for Equitable Allocation of Vaccine for the Novel Coronavirus

Dropdown items

Final Report Public Release Webinar: Framework for Equitable Allocation of COVID-19 Vaccine

Committee on Equitable Allocation of Vaccine for the Novel Coronavirus: Committee Meeting 7

Committee on Equitable Allocation of Vaccine for the Novel Coronavirus: Committee Meeting 6

Public Listening Session: Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine

Committee on Equitable Allocation of Vaccine for the Novel Coronavirus: Committee Meeting 5

Committee on Equitable Allocation of Vaccine for the Novel Coronavirus: Committee Meeting 4

Committee on Equitable Allocation of Vaccine for the Novel Coronavirus: Committee Meeting 3

Committee on Equitable Allocation of Vaccine for the Novel Coronavirus: Committee Meeting 2

Committee on Equitable Allocation of Vaccine for the Novel Coronavirus: Committee Meeting 1